The high predictive power of Apolipoprotein B and Apolipoprotein B/A1 ratio in CVD and early pre-disease condition, insulin resistance, diabetes, and metabolic syndrome (MS), have been highlighted in several studies [12,24,25,26,27]. This evidence concerns the gene APOB and metabolic syndrome.